Abnormal uterine bleeding is one of the common health concern affecting women of reproductive age, Abnormal uterine bleeding refers to the bleeding from the uterus that can be present in ways from infrequent episodes, to excessive flow or prolonged duration. The etiology varies with age, parity and may be attributed to both structural and non-structural causes(PALM COEIN)according to FIGO classification.It is a very frequent complaint that negatively affects the quality of life, hence, investigation for iron deficiency of anaemia is mandatory in these patients.The purpose of the recommendations, which include a list of side effects and indications for large blood loss, is to address the need to improve the lives of women. It was a Descriptive observational conducted to study the prevalence and management of Anaemia in women with abnormal uterine bleeding (AUB)in the department of Obstetrics and Gynecology, Malla Reddy Teaching Tertiary Care Hospital from August 2023 to January 2024. Details of 153 patients were recorded and analyzed with respect to age, parity, patterns, AUB according to PALM-COEIN, symptoms, treatment options were evaluated with menstrual history, physical examination, laboratory tests, pre and post iron supplementation for 4 weeks and were followed up from 1 to 2 months.
The study shows that The age range of 41-45 years old has the highest prevalence of AUB (44%), AUB and anaemia are significantly correlated (by 60%) moderate anaemia patients are more, 25% of patients had mild anaemia. Iron Supplementation Efficacy is beneficial in controlling hematologic issues caused by AUB, as evidenced by the 80% of cases in which anaemia was successfully corrected. Adenomyosis (AUB-A) is the most common group (67%), according to the PALM-COEIN classification system, which improves our understanding of various aetiologies. Analysis of menstrual patterns. Parity study shows a possible connection-most notably, among women in their 31–35 years of age range-between birthing experiences and AUB. The requirement for blood transfusions highlights the severity range within the AUB patients and is most common in cases of severe blood loss (21.56%).AUB is a widespread problem that impacts millions of women globally.